NYSE:RDY
Dr Reddy's Laboratories Ltd Stock News
$74.88
-0.330 (-0.439%)
At Close: May 06, 2024
Dr. Reddy's Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market
05:11am, Wednesday, 17'th Feb 2021
HYDERABAD, India and PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
07:38pm, Monday, 15'th Feb 2021
New York, New York--(Newsfile Corp. - February 15, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY)
Allstate, Cirrus Logic, EA, Zillow and More Tuesday Afternoon Analyst Calls
12:46pm, Tuesday, 02'nd Feb 2021
With the trading day more than halfway over, the broad markets were pushing much higher on Tuesday.
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market
04:20am, Tuesday, 02'nd Feb 2021
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Re
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
12:18am, Tuesday, 02'nd Feb 2021
NEW YORK, Feb. 2, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY). Such investors are
Dr. Reddy's (RDY) Q3 Earnings Decline Y/Y, Sales Increase
11:22am, Monday, 01'st Feb 2021
Dr. Reddy's (RDY) earnings decline while sales grow year over year in third-quarter fiscal 2021.
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q3 2021 Results - Earnings Call Transcript
10:59pm, Friday, 29'th Jan 2021
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q3 2021 Results - Earnings Call Transcript
Dr. Reddy's Q3 & 9M FY21 Financial Results
04:37am, Friday, 29'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and the
Dr. Reddy's (RDY) Ends Kuwait Study on Avigan for COVID-19
11:17am, Thursday, 28'th Jan 2021
Dr. Reddy's (RDY) and Global Response Aid FZCO terminate the Avigan study conducted in Kuwait, focused on moderate-to-severe COVID patients in a hospital setting.
Dr. Reddy's and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies
02:12pm, Wednesday, 27'th Jan 2021
KUWAIT CITY, Jan. 27, 2021 /PRNewswire/ -- Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to as "Dr. Reddy's") a
Dr. Reddy's and GRA announces Avigan Pivotal Studies Update
05:02am, Wednesday, 27'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy's”) and Glob
Dr. Reddy's (RDY) to Begin Phase III Study on Sputnik Vaccine
10:32am, Monday, 18'th Jan 2021
Dr. Reddy's (RDY) receives approval from the DCGI to conduct a phase III study on the Sputnik V vaccine for the treatment of COVID-19 in India.
Dr. Reddy's Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India
12:33pm, Friday, 15'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced today that it has received approval from the Drugs Control General of
Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market
04:59am, Monday, 11'th Jan 2021
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R
Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021
08:21am, Friday, 08'th Jan 2021
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the third quarter ended December 31, 2020 on Friday,